 MONMOUTH JUNCTION, N.J., Sept. 1, 2021 PRNewswire -- CytoSorbents Corporation NASDAQ: CTSO, a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using blood purification, announced that topline results from its CytoSorb Therapy in COVID-19 CTC multicenter registry were presented at the 40th International Symposium on Intensive Care and Emergency Medicine ISICEM 2021 in Brussels, Belgium yesterday. 